News
Hosted on MSN2mon
Globus Medical strengthens SCS market position with $250m Nevro dealGlobus expects the deal to close in the backend of Q2 2025. Globus CEO Dan Scavilla said the move enables the company to “expand into new markets for future growth, while gaining access to world ...
president and CEO of Globus Medical. The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic ...
It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. If you are thinking of buying or selling Globus Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results